Fibroblast Growth Factor 21 Correlates with the Prognosis of Dilated Cardiomyopathy
Conclusions: Serum FGF21 levels were associated with the risk factors, severity, and prognosis of DCM. Therefore, FGF21 may serve as a novel biomarker for the prognosis of DCM.Cardiology
Source: Cardiology - Category: Cardiology Source Type: research
More News: Atrial Fibrillation | Cardiology | Cardiomyopathy | Dilated Cardiomyopathy | Heart | Heart Failure | Laboratory Medicine | Study